Cortechs.ai | Dr. Suzie Bash Joins Cortechs.ai Medical Advisory Board

Dr. Suzie Bash Joins Cortechs.ai Medical Advisory Board

Neuroradiology expert to bring significant clinical expertise, ultimately allowing for better patient care

(SAN DIEGO) November 20, 2019 – Cortechs.ai Inc. is pleased to announce that Dr. Suzie Bash, one of the most highly regarded neuroradiologists in the United States (U.S.), has joined the company’s medical advisory board and will bring significant clinical expertise. Dr. Bash has been an expert user of Cortechs.ai’ volumetric magnetic resonance imaging (MRI) solution, NeuroQuant®, for over 12 years and is an avid supporter of the technology, contributing, as a user, to its development. This formalized relationship will provide a framework for more direct feedback and input to future product
development, allowing Cortechs.ai’ products to more directly address physician needs to provide
better patient care.

“We are extremely happy to welcome Dr. Bash to our medical advisory board,” said Dr. Chris Airriess,
chief executive officer of Cortechs.ai, “As one of the most respected and highly referred to neuroradiologists in the U.S., an early adopter of volumetric imaging and vocal supporter of Cortechs.ai’ suite of AI tools for advanced imaging, she will be a great resource, both internally to employees and externally to the health care providers we partner with.”

Dr. Bash is the medical director of neuroradiology at San Fernando Valley Interventional Radiology, part of the RadNet outpatient imaging network. Prior to joining RadNet in 2005, she was an assistant
professor of neuroradiology at the University of California, Los Angeles (UCLA) subsequent to a two-year neuroradiology fellowship and radiology residency at that institution. During her tenure at UCLA, Dr. Bash was the recipient of the Issa Yaghmai Scholarship for best paper published in a peer-reviewed
journal; Consultant of the Year Award, issued by the emergency department to one UCLA resident a
year; as well as the Outstanding Resident Award, issued by Olive View-UCLA to one resident a year.

“I have had long-standing interest in the potential of AI tools to transform neuroimaging studies into
more accurate, meaningful and clinically useful exams,” said Dr. Bash, “I am excited to be a part of a company that I have directly observed over the past 12 years elevate patient care through the use of
their pioneering volumetric MR post-processing tools.”

Dr. Bash was awarded James Scholar Honors during her medical school years at the University of Illinois. Dr. Bash’s passion and interests lie in artificial intelligence applications in neuroimaging and other advanced neuroimaging techniques which add patient-centric value and quality.

About Cortechs.ai
Cortechs.ai develops and markets breakthrough medical device software solutions capable of
automatically segmenting and quantifying brain structures, making quantitative analysis of the human
brain a routine part of clinical practice. Cortechs.ai’ cutting-edge brain imaging analysis provides
neurologists, radiologists and clinical researchers worldwide with a convenient and cost-effective means to quantify brain structures to help assess a variety of neurological conditions, such as Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma and brain development abnormalities. Please visit cortechs.ai for further information and follow us on Twitter, LinkedIn and Facebook.

###

More Resources

09/16/2025

OnQ Prostate for Focal Therapy

Read how OnQ Prostate supports focal therapy by personalizing prostate cancer care for patients while minimizing the risks associated with it.

09/03/2025

Reimbursement Considerations for OnQ Prostate and Category III CPT Codes 0648T & 0649T

Learn how Cat. III CPT codes 0648T and 0649T apply to OnQ™ Prostate, offering guidance for accurate reporting, reimbursement, and building evidence for coverage

09/02/2025

Maximizing the Value of Prostate MRI for the Urologist

Even with expert radiologists or AI models at hand, the challenge remains: how can urologists improve seeing and interpreting cancer?

08/18/2025

Why Bigger Normative Databases Mean Better Brain Imaging

NeuroQuant® 5.2 compares patient brain MRI volumes to over 7,000 healthy scans, giving clinicians clear, percentile-based context for better assessments.

08/07/2025

Navigating Reimbursement for NeuroQuant: Understanding CPT Codes 0865T & 0866T 

Let’s break down the latest category III CPT codes and example clinical use cases that illustrate their value.

07/31/2025

Precision Without the Pressure: Smarter Brain Tumor Monitoring

Learn about NeuroQuant Brain Tumor 2.0 and how it assists clinicians by providing objective quantification and analysis of tumor changes over time.
Scroll to Top